Drugs Made In America Acquisition (DMAAR) Income towards Parent Company (2025)
Drugs Made In America Acquisition (DMAAR) reported Income towards Parent Company of $212958.0 for Q4 2025, down 90.25% quarter-over-quarter from $2.2 million in Q3 2025.
Drugs Made In America Acquisition (DMAAR) Income towards Parent Company (2025) Analysis & Trends
Drugs Made In America Acquisition has reported Income towards Parent Company for 1 years, with the latest figure at $212958.0 in Q4 2025.
- For the quarter ending Q4 2025, Income towards Parent Company changed N/A year-over-year to $212958.0; the trailing twelve-month figure through Dec 2025 stood at $5.9 million (changed N/A YoY), and the FY2025 full-year result was $5.9 million, up 2222.83% from the prior year.
- Income towards Parent Company for Q4 2025 stood at $212958.0, down from $2.2 million in the prior quarter.
- The five-year high for Income towards Parent Company was $2.3 million in Q2 2025, with the low at $212958.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - |
| 2 | Centurion Acquisition | 312.80 Mn | 312.80 Mn | - |
| 3 | Berto Acquisition | 312.16 Mn | 312.16 Mn | - |
| 4 | GP-Act III Acquisition | 311.36 Mn | 311.36 Mn | - |
| 5 | Churchill Capital Corp IX | 310.50 Mn | 310.50 Mn | - |
| 6 | WEN Acquisition | 308.55 Mn | 308.55 Mn | - |
| 7 | Agriculture & Natural Solutions Acquisition | 304.08 Mn | 304.08 Mn | - |
| 8 | Bold Eagle Acquisition | 274.25 Mn | 274.25 Mn | - |
| 9 | Soulpower Acquisition | 265.04 Mn | 265.04 Mn | - |
| 10 | Drugs Made In America Acquisition | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 212,958.00 |
| Sep 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Mar 31, 2025 | 1.25 Mn |